STAT+: Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness
BARCELONA, Spain — Patients with advanced cancers often develop a secondary condition that causes them…
Category: #Pfizer
Opinion: How Pfizer ended up passing on my GLP-1 work back in the early ’90s
One of the biopharma industry’s marvels of the 2020s has been the enormous medical and…
STAT+: Vaxcyte shares boom as one of biotech’s big David vs. Goliath stories heats up
With new vaccine data released Tuesday, Vaxcyte, a San Carlos, Calif.-based firm, emerged as one…
STAT+: To help migraine patients — and sell more medicines — major drugmakers turn to telehealth
In 2021, Katey Frederking had reached the end of her rope. The 29-year-old was struggling…
STAT+: Pfizer and BioNTech effort to develop Covid-influenza combination vaccine sees setback
Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19…
STAT+: How Pfizer’s grand gene therapy ambitions crumbled
A decade ago, Pfizer began investing heavily in gene therapy, bringing in experimental treatments for…
STAT+: Pfizer gene therapy reduced hemophilia bleeds, but questions remain
Pfizer said Wednesday that its gene therapy for hemophilia A successfully reduced patients’ bleeds for…
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout…
STAT+: Pfizer says it will advance once-daily GLP-1 pill after all
Pfizer said that it plans to advance a new once-a-day formulation of its experimental obesity…
STAT+: Mikael Dolsten, Pfizer CSO who could take on Covid but not Wall Street, to step down
Five years ago — before the pandemic — Pfizer’s head of research and development, Mikael…
STAT+: U.K. trade group scolds Novo, Novartis, Pfizer and Otsuka for violating industry codes
Four large drugmakers — Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical — were scolded by…
CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines
Makers of RSV vaccines for older adults saw their plans to try to expand usage…
.jpg)
STAT+: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in phase 3 trial
Pfizer said Wednesday afternoon that a closely watched gene therapy for Duchenne muscular dystrophy failed…
STAT+: Young boy dies in trial for Pfizer Duchenne gene therapy
A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular…
STAT+: Biden administration urged to license prostate cancer drug patents in a bid to lower its cost
In the latest gambit to lower the cost of a pricey medicine, three advocacy groups…
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people…
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Drug development is more of a sprint than a marathon these days, thanks to more…
STAT+: J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer
Johnson & Johnson has accused a long-standing employee of taking thousands of confidential files about…
STAT+: Here are the cancer drugs Pfizer thinks could reignite investors’ interest
Pfizer spent more than four hours Thursday laying out its oncology program to investors. But…
STAT+: Pfizer is about to make a big push in cancer. Will investors listen?
Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer…
Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?
Super Bowl ads are a show within the show, an opportunity for brands and advertising…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
STAT+: More patients are getting their meds online. Big Pharma wants in on the action
Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth…
STAT+: Another major pharma company departs BIO
WASHINGTON — UCB left BIO at the end of 2023, the second major member company to…
Here are the worst biopharma CEOs of 2023
Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of…
Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally…
STAT+: Pfizer says 2024 profits will fall far below expectations
Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares…
STAT+: Pfizer plans to depart BIO
WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources…
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
Here are two things that are true. The world needs more effective flu vaccines. And…
Pfizer RSV vaccine wins recommendation for seasonal use only
Pfizer’s new shot to protect infants against respiratory syncytial virus by vaccinating their mothers late…
FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent
The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect…
Coronavirus hasn’t developed resistance to Paxlovid. How long can that last?
When the patient came back 10 days later, coughing repeatedly and complaining of headache, Davey…
Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Dateline City: KENILWORTH, N.J. & NEW YORK & INDIANAPOLIS Three leading biopharmaceutical companies have announced…